Topics
Glioblastoma | Treatment | Targeted therapy | Lisavanbulin
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Lisavanbulin
Holdhoff M, Ye X, Strowd RE, Nabors B, Walbert T, Lieberman FS,
Bagley SJ, Fiveash JB, Fisher JD, Desideri S, Surakus T,
Engelhardt M, Kaindl T, Lane HA, Litherland K, Grossman SA,
Kleinberg LR.
Lisavanbulin
(BAL101553), a novel microtubule
inhibitor, plus radiation in patients with newly diagnosed, MGMT
promoter unmethylated glioblastoma.
Neurooncol
Adv. 2024 Aug 28;6(1):vdae150. doi:
10.1093/noajnl/vdae150. PMID:
39371261. Interventional study. ˍ